“…ICK has been classically described in patients with topical immunosuppression following a penetrating keratoplasty (PK) and is notoriously difficult to treat [ 1 , 5 ]. ICK has also been described in patients treated with immunosuppressive agents for other ocular or systemic conditions including Stevens-Johnson syndrome, and chronic graft-vs.-host disease (GVHD) [ 6 , 7 ]. Although local or systemic immunosuppression often precedes ICK, this condition has been linked to neurotrophic corneal diseases such as herpetic keratitis, denervation after corneal surgery (PK [ 2 , 8 ], laser-assisted in situ keratomileusis (LASIK) [ 9 ]), or even after long-term topical anesthetic use [ 10 ] in the absence of immunosuppression.…”